Urispas Product Description
Urispas is an oral antispasmodic drug approved to prevent bladder spasms caused by urethral catheterization, infectious and /or inflammatory diseases of the urogenital system or neurological disorders.
Due to the fact that Urispas exerts an antispasmodic effect on the bladder, it is possible to restore quickly the ability to control urination, to reduce the frequency of urination, as well as to alleviate the burning sensation, pain, and discomfort during urination. Urispas tablets can be administered to children older than 12 years and adults to:
- alleviate suprapubic pain in patients with painful bladder syndrome;
- reduce discomfort or burning during urination in patients with dysuria;
- reduce urinary urgency and frequency of urination at night in patients with nocturia;
- prevent sudden, strong urge to urinate and ease discomfort in bladder in patients with and without urinary tract infection;
- prevent bladder spasms before urethral catheterization in postoperative period;
- prevent spasms in the bladder and urinary tract in patients with overactive bladder syndrome.
If it is happened that you’ve missed a usual dose of Urispas, check if it is not almost time for the next tablet. If it is, just skip the missed dose of Urispas and return to your regular dosing schedule.
To relieve painful urination and improve urodynamic parameters, more than 4 Urispas 200mg tablets in four divided doses can be used per day.
The optimal storage temperature of Urispas is 25°C, herewith a short storage of tablets at temperature of 15°C-30°C is permitted.
Urispas Safety Information
If changed urodynamics and discomfort in urination are associated with urinary tract infections, the antimicrobial therapy should be assigned together with Urispas tablets.
All the information about bladder problems published in the Urispas review is provided as general information only and is not a substitute for a professional medical advice provided by the licensed medical professional. The online pharmacy shall not accept any liability for damages or actions arising from the misinterpretation or use of information about Urispas antispasmodic agent.
Urispas Side Effects
The frequency and intensity of Urispas side effects are usually very low. The most common side effects of Urispas antiepileptic agent include erythema, dysuria, leukopenia, pruritus, angioedema, hyperpyrexia, hypersensitivity reactions, urticaria, eosinophilia, fatigue or rash. In addition to these side effects, Urispas may cause other disorders, such as tachycardia, palpitations; gastrointestinal diseases (dyspepsia, diarrhoea, vomiting, nausea, dysphagia, dry mouth); CNS disorders (nervousness, headache, vertigo or mental confusion).